Increased levels of E2f1 are associated with melanomas, while reduced levels precipitate melanoma cell death, strongly suggesting that E2f1 could be a diagnostic melanoma biomarker (Rouaud et al., 2018). This evidence concerns the gene E2F1 and melanoma.